Novel 1,2,3-Triazole Erlotinib Derivatives as Potent IDO1 Inhibitors: Design, Drug-Target Interactions Prediction, Synthesis, Biological Evaluation, Molecular Docking and ADME Properties Studies

Guiqing Xu, Xiaoqing Gong, Yingying Zhu, Xiaojun Yao, Lizeng Peng, Ge Sun, Jianxue Yang, Longfei Mao

Frontiers in Pharmacology · 2022 · 21 citations · 23 references

DOIFull text

Open access

Concepts

Abstract

was a novel and interesting IDO1 inhibitor for further development.

References

23